Publications
5539 Results
- Journal / Conference
- Blood 98(11):343a(#1448)
- Year
- 2001
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-9349
Dose-intense CHOPx2 therapy of intermediate grade lymphoma -- a phase II study of the Southwest Oncology Group (SWOG)
- Journal / Conference
- Blood 98(11):843a(#3502)
- Year
- 2001
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S9800
A phase II trial of CHOP followed by rituximab chimeric monoclonal anti-CD20 antibody for treatment of newly diagnosed follicular non-Hodgkin's lymphoma: SWOG 9800
- Journal / Conference
- Blood 98(11):125a(#526)
- Year
- 2001
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Cellular proteins determined by immunohistochemistry predict outcome in patients with aggressive non-Hodgkin's lymphoma: a first generation model of risk.
- Journal / Conference
- Blood 98(11):724a-725a(#3024)
- Year
- 2001
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8736 (INT-0093)
CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkins lymphomas: update of the Southwest Oncology Group (SWOG) randomized trial.
- Journal / Conference
- Blood 98(11):457a(#1913)
- Year
- 2001
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9007
Prognostic implication of additional cytogenetic aberrations in denovo acute myeloid leukemia (AML) with t(15:17), t(8;21) or inv(16)/t(16;16).
- Journal / Conference
- American Journal of Human Genetics 69(4):232(#285)
- Year
- 2001
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8750, SWOG-9007, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9129 (INT-0129), SWOG-9333, SWOG-9500
The significance of trisomy 8 in myeloid leukemia: a Southwest Oncology Group (SWOG) study.
- Journal / Conference
- Current Treatment Options in Oncology 2(1):15-23
- Year
- 2001
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)
Locally advanced nasopharyngeal cancer
- Journal / Conference
- Int J Radiat Oncol Biol Phys 51(3):166(#297)
- Year
- 2001
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9310 (INT-0143) (RTOG-93-10)
Secondary analyis of RTOG 9310: an Intergroup phase II combined modality treatment of primary central nervous system lymphoma with chemotherapy and hyperfractionated radiotherapy
- Journal / Conference
- Nutrition and Cancer 39(1):12-18
- Year
- 2001
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Dietary supplement use in the prostate cancer prevention trial: implications for prevetion trials.
- Journal / Conference
- Blood 97(5):1427-1434
- Year
- 2001
- Research Committee(s)
- Leukemia